AureoGen Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Out of Business

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Out of Business

AureoGen General Information

Description

Developer of novel chemistry and genetic engineering methodologies utilizing chemistry and genetic engineering from existing cyclic peptide templates. The company offers advances in medicinal chemistry to develop novel approaches that allow efficient, cost-effective modification, optimization, and production of cyclic peptide compounds, allowing clients to introduce modifications to cyclic peptides directly, without the need for the multiple synthesis steps that characterize older approaches.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 4717 Campus Drive
  • Suite 2300
  • Kalamazoo, MI 49008
  • United States
Primary Industry
Discovery Tools (Healthcare)
Vertical(s)
Corporate Office
  • 4717 Campus Drive
  • Suite 2300
  • Kalamazoo, MI 49008
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

AureoGen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
15. Out of Business 24-Feb-2024 Completed Out of Business
14. Secondary Transaction - Private 01-Apr-2023 Completed Generating Revenue
13. Later Stage VC 31-Jan-2014 Completed Generating Revenue
12. Grant 31-Jan-2013 Completed Generating Revenue
11. Grant 31-Mar-2011 Completed Generating Revenue
10. Grant 31-May-2010 Completed Generating Revenue
9. Grant 31-Mar-2009 Completed Generating Revenue
8. Grant 01-Jun-2008 Completed Generating Revenue
7. Grant 27-Mar-2008 $600K $2.42M Completed Generating Revenue
6. Grant 31-May-2007 $638K $2.42M Completed Generating Revenue
To view AureoGen’s complete valuation and funding history, request access »

AureoGen Patents

AureoGen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2017308814-A1 Aureobasidium derivatives and methods of synthesis Active 08-Aug-2016
AU-2017308814-B2 Aureobasidium derivatives and methods of synthesis Inactive 08-Aug-2016
CA-3033500-A1 Aureobasidium derivatives and methods of synthesis Inactive 08-Aug-2016
EP-3497113-A1 Aureobasidium derivatives and methods of synthesis Inactive 08-Aug-2016
US-11066447-B2 Aureobasidium derivatives and methods of synthesis Inactive 08-Aug-2016 C07K11/02
To view AureoGen’s complete patent history, request access »

AureoGen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

AureoGen FAQs

  • When was AureoGen founded?

    AureoGen was founded in 2003.

  • Where is AureoGen headquartered?

    AureoGen is headquartered in Kalamazoo, MI.

  • What is the size of AureoGen?

    AureoGen has 2 total employees.

  • What industry is AureoGen in?

    AureoGen’s primary industry is Discovery Tools (Healthcare).

  • Is AureoGen a private or public company?

    AureoGen is a Private company.

  • What is AureoGen’s current revenue?

    The current revenue for AureoGen is .

  • How much funding has AureoGen raised over time?

    AureoGen has raised $2.76M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process